2,3,4,4A-Tetrahydro-1H-pyrazino[1,2-a,]quinoxalin-5(6H)-ones and
derivatives thereof for relieving hypertension
    12.
    发明授权
    2,3,4,4A-Tetrahydro-1H-pyrazino[1,2-a,]quinoxalin-5(6H)-ones and derivatives thereof for relieving hypertension 失效
    2,3,4,4A-四氢-1H-吡嗪{8,1-a,{9喹喔啉-5(6H)酮及其衍生物用于缓解高血压

    公开(公告)号:US4032639A

    公开(公告)日:1977-06-28

    申请号:US668872

    申请日:1976-03-22

    CPC分类号: C07D487/04

    摘要: Compounds of the formula ##STR1## wherein R is hydrogen (lower)alkyl, phen(lower)alkyl, benzoyl(lower)alkyl, or p-halobenzoyl(lower)alkyl; R.sup.1 is hydrogen or (lower)alkyl; R.sup.2 is hydrogen, (lower)alkyl, (lower)alkoxy, chlorine, fluorine, trifluoromethyl, or amino in the 7-, 8-, or 9-position; R.sup.3 is hydrogen, or (lower)alkyl; and R.sup.4 is hydrogen, (lower)alkyl, (lower)alkoxy, chlorine, fluorine, or trifluoromethyl in the 7-, 8-, or 9-position; or the non-toxic acid addition salts thereof; exert a hypotensive effect in hypertensive animals.

    摘要翻译: 其中R为氢(低级)烷基,苯基(低级)烷基,苯甲酰基(低级)烷基或对卤代苯甲酰基(低级)烷基)的化合物。 R1是氢或(低级)烷基; R2是氢,(低级)烷基,(低级)烷氧基,氯,氟,三氟甲基或氨基在7-,8-或9-位; R3是氢或(低级)烷基; 并且R 4为氢,(低级)烷基,(低级)烷氧基,氯,氟或三氟甲基,在7-,8-或9-位; 或其无毒的酸加成盐; 在高血压动物中发挥降压作用。

    Tetra- and hexa-hydropyrrolo(1,2-a)quinoxaline and azaquinoxaline
derivatives
    15.
    发明授权
    Tetra- and hexa-hydropyrrolo(1,2-a)quinoxaline and azaquinoxaline derivatives 失效
    四 - 和六氢吡咯并(1,2-a)喹喔啉和氮杂喹喔啉衍生物

    公开(公告)号:US4446323A

    公开(公告)日:1984-05-01

    申请号:US496791

    申请日:1983-05-23

    摘要: Tetra- and hexa-hydropyrrolo[1,2-a]quinoxaline and azaquinoxaline derivatives of the formula: ##STR1## in which X is O or H.sub.2 ;Y is CH or N;R is hydrogen, alkyl, dialkylaminoalkyl, arylalkyl, phenoxyalkyl, benzoyl, pyridylalkyl or variations thereof; andR.sup.1 is hydrogen, alkyl, alkoxy, nitro, halo, trifluoromethyl, amino, alkylamino or dialkylamino;or pharmaceutically acceptable salts thereof; are anti-hypertensive agents.

    摘要翻译: 四 - 和六氢 - 咯罗咯[1,2-a]喹喔啉和下式的氮杂喹喔啉衍生物:其中X是O或H 2; Y是CH或N; R是氢,烷基,二烷基氨基烷基,芳基烷基,苯氧基烷基,苯甲酰基,吡啶基烷基或其变体; R 1为氢,烷基,烷氧基,硝基,卤素,三氟甲基,氨基,烷基氨基或二烷基氨基; 或其药学上可接受的盐; 是抗高血压药。

    4-Substituted-piperidino carboxamides
    16.
    发明授权
    4-Substituted-piperidino carboxamides 失效
    4-取代的哌啶子基甲酰胺

    公开(公告)号:US4414389A

    公开(公告)日:1983-11-08

    申请号:US381673

    申请日:1982-05-25

    申请人: Meier E. Freed

    发明人: Meier E. Freed

    IPC分类号: C07D487/04 A61K31/495

    CPC分类号: C07D487/04

    摘要: The compounds ##STR1## where R is hydrogen, alkyl, phenyl or substituted phenyl and R.sup.1 is 2-furanyl, 2-benzofuranyl, 2-thienyl or 2-pyridyl or pharmaceutically acceptable salts thereof are antihypertensive, antisecretory agents.

    摘要翻译: 其中R为氢,烷基,苯基或取代的苯基,R1为2-呋喃基,2-苯并呋喃基,2-噻吩基或2-吡啶基或其药学上可接受的盐的化合物为抗高血压抗分泌剂。

    4-Carbobenzoxypiperazine-2-carboxylic acid chemical intermediate
    18.
    发明授权
    4-Carbobenzoxypiperazine-2-carboxylic acid chemical intermediate 失效
    4-羧基苯甲氧基哌嗪-2-羧酸化学中间体

    公开(公告)号:US4182869A

    公开(公告)日:1980-01-08

    申请号:US945356

    申请日:1978-09-25

    CPC分类号: C07D487/04

    摘要: Compounds of the formula ##STR1## wherein R is hydrogen (lower)alkyl, phen(lower)alkyl, benzoyl(lower)alkyl, or p-halobenzoyl(lower)alkyl; R.sup.1 is hydrogen or (lower)alkyl; R.sup.2 is hydrogen, (lower)alkyl, (lower)alkoxy, chlorine, fluorine, trifluoromethyl, or amino in the 7-, 8-, or 9-position; R.sup.3 is hydrogen, or (lower)alkyl; and R.sup.4 is hydrogen, (lower)alkyl, (lower)alkoxy, chlorine, fluorine, or trifluoromethyl in the 7-, 8-, or 9-position; or the non-toxic acid addition salts thereof; exert a hypotensive effect in hypertensive animals. Also disclosed are chemical intermediates including 4-carbobenzoxypiperazine-2-carboxylic acid.

    摘要翻译: 其中R为氢(低级)烷基,苯基(低级)烷基,苯甲酰基(低级)烷基或对卤代苯甲酰基(低级)烷基)的化合物。 R1是氢或(低级)烷基; R2是氢,(低级)烷基,(低级)烷氧基,氯,氟,三氟甲基或氨基在7-,8-或9-位; R3是氢或(低级)烷基; 并且R 4为氢,(低级)烷基,(低级)烷氧基,氯,氟或三氟甲基,在7-,8-或9-位; 或其无毒的酸加成盐; 在高血压动物中发挥降压作用。 还公开了包括4-苄氧羰基哌嗪-2-羧酸的化学中间体。

    N-Carbobenzoxy-N'-(2-nitrophenyl)-2-piperazine carboxylic acid
    19.
    发明授权
    N-Carbobenzoxy-N'-(2-nitrophenyl)-2-piperazine carboxylic acid 失效
    N-苄氧基-N- {40 - (2-硝基苯基)-2-哌嗪羧酸

    公开(公告)号:US4138567A

    公开(公告)日:1979-02-06

    申请号:US835560

    申请日:1977-09-22

    摘要: Compounds of the formula ##STR1## wherein R is hydrogen (lower)alkyl, phen(lower)alkyl, benzoyl(lower)alkyl, or p-halobenzoyl(lower)alkyl; R.sup.1 is hydrogen or (lower)alkyl; R.sup.2 is hydrogen, (lower)alkyl, (lower)alkoxy, chlorine, fluorine, trifluoromethyl, or amino in the 7-, 8-, or 9-position; R.sup.3 is hydrogen, or (lower)alkyl; and R.sup.4 is hydrogen, (lower)alkyl, (lower)alkoxy, chlorine, fluorine, or trifluoromethyl in the 7-, 8-, or 9-position; or the non-toxic acid addition salts thereof; exert a hypotensive effect in hypertensive animals.

    摘要翻译: 其中R为氢(低级)烷基,苯基(低级)烷基,苯甲酰基(低级)烷基或对卤代苯甲酰基(低级)烷基)的化合物。 R1是氢或(低级)烷基; R2是氢,(低级)烷基,(低级)烷氧基,氯,氟,三氟甲基或氨基在7-,8-或9-位; R3是氢或(低级)烷基; 并且R 4为氢,(低级)烷基,(低级)烷氧基,氯,氟或三氟甲基,在7-,8-或9-位; 或其无毒的酸加成盐; 在高血压动物中发挥降压作用。

    Benzobicycloalkane amines
    20.
    发明授权
    Benzobicycloalkane amines 失效
    苯并二环烷胺

    公开(公告)号:US3979434A

    公开(公告)日:1976-09-07

    申请号:US553406

    申请日:1975-02-26

    IPC分类号: C07C93/26

    摘要: Benzobicycloalkane amines, their pharmacologically acceptable addition salts, intermediates therefore the processes for their preparation and use. The compounds of the invention exert analgesic and anti-inflammatory activity.

    摘要翻译: 苯并双环链烷胺,其药理学上可接受的加成盐,因此其中间体是其制备和使用的方法。 本发明化合物发挥止痛和抗炎活性。